Novartis News | finanzen.ch

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Strukturierte Produkte

Aktion

Portfolio

Watchlist

20.05.09	HUGIN NEWS/Sandoz übernimmt das Spezial-Geschäft generischer Arzneimittel von EBEWE Pharma und verbessert damit den Zugang zu injizierbaren Krebsmedikamen... (Dow Jones)
20.05.09	HUGIN NEWS/Sandoz übernimmt das Spezial-Geschäft -2- (Dow Jones)
12.06.08	HUGIN NEWS/American Express und A.T. Kearney: Europas Unternehmen bekommen Verwaltungskosten für Geschäftsreisen nicht in den Griff (Dow Jones)
02.06.08	Early Data Presented at ASCO Show Potential Of RAD001 to Enhance Efficacy of, and Overcome Resistance to, Breast Cancer Treatments (PR Newswire)
26.05.08	Novartis: Extavia erhält EU-Zulassung zur MS-Behandlung (Dow Jones)
19.05.08	RAD001 More Than Doubles Time Without Tumor Growth After Failure of Standard Treatment in Patients With Advanced Kidney Cancer (PR Newswire)
06.05.08	HUGIN NEWS/Zulassungsentscheidende Phase -2- (Dow Jones)
06.05.08	HUGIN NEWS/Zulassungsentscheidende Phase III-Studie: In Entwicklung befindlicher Meningokokken ACWY-Konjugat-Impfstoff von Novartis zeigt überlegene Immun... (Dow Jones)
16.04.08	Novartis sieht Multiple-Sklerose-Mittel FTY720 im Zeitplan (Dow Jones)
15.04.08	FTY720, a novel oral therapy in development for MS, shows sustained benefits for the majority of patients after three years of treatment (PR Newswire)
31.03.08	Lotrel, a Single-Pill Combination for Treating High Blood Pressure, Reduced Cardiovascular Events by 20% in High-Risk Patients (PR Newswire)
10.03.08	VIDEO: Femara(R) helps protect against return of breast cancer even when treatment starts several years after completing tamoxifen therapy (PR Newswire)
28.02.08	Everolimus (RAD001) Significantly Extends Progression-Free Survival in Advanced Kidney Cancer Patients After Failure of Other Targeted Therapy (PR Newswire)
26.02.08	HUGIN NEWS/Die Aktionäre von Novartis nehmen im Rahmen ihrer ordentlichen Generalversammlung 2008 alle Anträge an, einschliesslich der Dividendenerhöhung ... (Dow Jones)
08.01.08	ROUNDUP: Kartellamt verhängt Geldbussen wegen Apotheken-Preisen (dpa-afx)
12.12.07	Once-Daily Exjade(R) Shown to Remove Toxic Iron From the Heart and Liver, According to Data Presented at ASH (PR Newswire)
12.12.07	Once-Daily Exjade(R) Shown to Remove Toxic Iron From the Heart and Liver, According to Data Presented at ASH (PR Newswire)
09.12.07	Photo: New Data Show Gleevec(R) Halts Progression to Advanced Stages of Life-Threatening Form of Leukemia in Sixth Year of Treatment (PR Newswire)
03.12.07	FDA Approves Diovan(R) for Treatment of High Blood Pressure in Children (PR Newswire)
13.11.07	Novartis Vaccines to Host Holiday Vaccination Clinic, Making Influenza Vaccination Convenient for Shoppers (PR Newswire)
22.10.07	Exelon(R) (rivastigmine) Transdermal Patch: First and Only Skin Patch for Alzheimer's Disease Provides Novel Treatment Approach (PR Newswire)
22.10.07	Voltaren(R) Gel Receives US Regulatory Approval as the First Approved Topical Prescription Treatment for Pain Associated with Osteoarthritis (PR Newswire)
22.10.07	Voltaren(R) Gel Receives US Regulatory Approval as the First Approved Topical Prescription Treatment for Pain Associated with Osteoarthritis (PR Newswire)
18.09.07	First Osteoporosis Study in Hip Fracture Patients Finds Once-Yearly Reclast(R) Prevents Additional Fractures and Improves Survival (PR Newswire)
29.08.07	HUGIN NEWS/Novartis gibt die Pensionierung von Urs Bärlocher bekannt (Dow Jones)
21.06.07	Novartis: Exforge Gets Final US Approval -2- (Dow Jones)
15.06.07	Lumiracoxib Study Showed Significantly Less Impact on Blood Pressure Than Ibuprofen in Osteoarthritis Patients with Controlled Hypertension (PR Newswire)
17.04.07	Reclast(R) Receives US Approval as a Highly Effective Treatment for Patients with Paget's Disease of the Bone (PR Newswire)
26.03.07	Tekturna(R), First New Type of High Blood Pressure Medicine in a Decade, Provides Additional Blood Pressure Reduction When Used With Diovan(R) (PR Newswire)
06.12.06	New Evidence Reinforces Efficacy and Tolerability of Galvus(R) as a New Once-Daily Oral Treatment Option for Patients With Type 2 Diabetes (PR Newswire)
22.11.06	Schering reicht wegen "Betaferon" Klage gegen Novartis ein (Dow Jones)
27.10.06	New Telbivudine Data From Three Clinical Trials to be Presented This Week at the American Association for the Study of Liver Diseases (AASLD) (PR Newswire)
26.10.06	New BOOST(R) Glucose Control(TM) Helps Provide Optimal Blood Sugar Control for People with Diabetes (Businesswire)
18.10.06	AUDIO from Medialink: Visions of Halloween Fun (Businesswire)
17.10.06	Celebrity Photographer Jeremy Kost Creates Images of Isolation to Empower Eczema Patients to Share Their Stories and Take Control (PR Newswire)
05.10.06	New Treatment Significantly Improves Vision in Patients With Wet Age-Related Macular Degeneration - The Leading Cause of Blindness in the UK (PR Newswire)
04.10.06	Millions Live with Painful GI Symptoms Impacting Their Lives, but Sufferers Rarely Discuss Symptoms with Doctors Due to Fear and Embarrassment (PR Newswire)
28.09.06	New Data for FTY720 -- Aiming to Become the First Orally Effective Multiple Sclerosis Treatment -- Show Sustained Benefits Over Two Years (PR Newswire)
21.09.06	No More Needles - a New Breakthrough for Iron Overload (PR Newswire)
21.09.06	No More Needles - A New Breakthrough for Iron Overload (PR Newswire)
29.08.06	Tennis Mom Betty Agassi Shares Her Battle With Breast Cancer and Champions Disease Awareness at the US Open (PR Newswire)
14.08.06	Schering-Plough Announces Global Agreement With Novartis to Develop Once-Daily Combination Therapy for Asthma and COPD (PR Newswire)
11.08.06	Women With Breast Cancer No Longer Have to Settle for Second Class Treatments (PR Newswire)
25.07.06	From Touchdowns to Touching Lives: Football Superstar Tiki Barber Aims to Make a 'Giant' Difference for Children and Their Families Coping With Sickle Cell Disease (PR Newswire)
24.07.06	Study Shows Neoral(R) Provides Kidney Transplant Patients With Efficacy Equivalent to Tacrolimus and Significantly Lower Incidence of Diabetes (PR Newswire)
18.07.06	Novartis to Build Latest-Technology Influenza Vaccines Manufacturing Site in North Carolina (PR Newswire)
14.06.06	Patients With Treatment-Resistant Leukemia Achieve High Responses to Tasigna(R) (nilotinib) in First Published Clinical Trial Results (PR Newswire)
13.06.06	Novartis Unveils Further Impressive Efficacy Data for Galvus(R), an Investigational Oral Diabetes Compound, Showing Significant Blood Sugar Reductions (PR Newswire)
24.05.06	The First and Only Medicine for Parkinson's Disease Dementia is Now Available (PR Newswire)
23.05.06	New Data Show Overactive Bladder Therapy Enablex(R) Does Not Impair Memory Function Compared to Frequently Used Alternative (PR Newswire)

Newssuche

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Part Grp Hldg	1’263.50	2.89 %	K V
Sonova Hldg	312.10	2.66 %	K V
Novartis	93.68	2.32 %	K V
Geberit	526.80	1.97 %	K V
Roche Hldg G	254.30	1.27 %	K V
Kuehne+Nagel Int	209.50	0.72 %	K V
UBS Group	28.30	0.57 %	K V
Givaudan	3’933.00	0.36 %	K V
Nestle	76.00	0.05 %	K V
Lonza Grp	521.40	-0.04 %	K V

mehr

12.07.24		Novartis- und MorphoSys-Aktien gewinnen: Novartis kurbelt Squeeze-Out bei MorphoSys an
12.03.24		MorphoSys- und Novartis-Aktien uneinig: Bundeskartellamt erlaubt MorphoSys-Übernahme durch Novartis
31.01.24		Novartis-Aktie schwach: Novartis profitiert von Sandoz-Abspaltung - Gewinnsprung
12.06.23		Novartis-Aktie im Plus: Novartis legt für Chinook Milliardensumme auf den Tisch
25.04.23		Novartis-Aktie im Plus: Novartis hebt nach gutem Jahresbeginn die Umsatzprognose an
07.12.22		MorphoSys-Aktie und Novartis-Aktie gefragt: Krebsprogramm gegen Zahlung an Novartis auslizenziert
19.07.22		Novartis-Aktie höher: Novartis bei nahezu stabilen Umsätzen mit Gewinnrückgang - Umbau soll 1,5 Milliarden US-Dollar Kosten sparen
06.05.22		Novartis-Aktie im Minus: Produktion von Krebsmitteln in Italien und USA ausgesetzt